Gland Pharma informs about press release

03 Dec 2024 Evaluate
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma has informed that it attached announcement regarding the receipt of US FDA approval for Latanoprost Ophthalmic Solution, 0.005% (2.5 mL Fill).

The above information is a part of company’s filings submitted to BSE.

Gland Pharma Share Price

1640.95 -12.40 (-0.75%)
29-Dec-2025 12:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1727.80
Dr. Reddys Lab 1262.90
Cipla 1500.50
Zydus Lifesciences 904.60
Lupin 2096.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×